19 completed, 8 terminated, 7 unknown, 4 not yet recruiting. 11 Not applicable, 11 Phase 4, 10 Phase 3, 4 Phase 2, 3 Phase 1.
Follow Utrogestan: new trials by email Literature Review of Utrogestan trials Research Report on Utrogestan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET) Oestrogel® 0.75 mg (estradiol transdermal gel), Progesterone 200 mg vaginal capsules, Endometrial biopsy - Fertility, Implantation, Embryo | Phase 4 | Not yet recruiting | University Hospital, Ghent | 70 | 2026-10-01 | 2026-09-14 |
| Progesterone Luteal Support in Unexplained Infertility Management Utrogestan® 200 mg Soft Capsule, Placebo soft capsule 200 mg - Infertility, Female Infertility | Phase 3 | Not yet recruiting | Simone Broer | 640 | 2026-08-01 | 2026-07-30 |
| Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix Cervical cerclage, Progesterone - Preterm | Not applicable | Recruiting | National Hospital of Obstetrics and Gynecology | 260 | 2026-04-10 | 2026-04-24 |
| Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles no luteal support, Vaginal Progesterone, Progesterone plus HCG - Luteal Support, Frozen Embryo Transfer (FET) | Phase 4 | Recruiting | Dunamenti REK Istenhegyi IVF Center | 180 | 2025-04-12 | 2025-07-25 |
| Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone Nafarelin nasal spray, Utrogestan® - Ivf, Frozen Embryo Transfer (FET) | Early Phase 1 | Not yet recruiting | Shaare Zedek Medical Center | 150 | 2025-03-01 | 2025-03-11 |
| Verify the Safety and Effectiveness of the Cerclage Pessary in Prevention and Treatment of High-risk Preterm Pregnancy Progesterone, pessary - High Risk Pregnancy | Not applicable | Not yet recruiting | QH Medical Technology Ltd. | 300 | 2024-12-01 | 2023-11-18 |
| Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment Progesterone Vaginal Product, Placebo - Pregnancy Related, Fertility Issues | Phase 4 | Recruiting | UMC Utrecht | 1008 | 2023-03-01 | 2025-12-31 |
| Natural Progesterone for the Treatment of Recurrent Glioblastoma Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Progesterone - Gliosarcoma, Recurrent Glioblastoma | Early Phase 1 | Terminated | Emory University | 4 | 2022-04-11 | 2026-05-05 |
| Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles Utrogestan - Luteal Phase | Unknown | University of Athens | 698 | 2021-09-14 | 2021-10-22 | |
| GnRH Agonist for Luteal Phase Support. GnRH agonist, Progesterone - Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles | Not applicable | Unknown | Shaare Zedek Medical Center | 150 | 2020-06-08 | 2022-08-02 |
| Vaginal Progesterone for the Prevention of Preterm Birth in Twins Progesterone - Premature Birth, Twin Pregnancy | Phase 3 | Withdrawn | Chiu Yee Liona Poon | 2020-04-01 | 2021-01-28 | |
| Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects Progesterone 200 mg Soft Capsule (JSC "Farmak", Ukraine), Utrogestan® 200 mg Soft Capsule (Manufacturer by: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France) - Pharmacokinetics | Phase 1 | Completed | Joint Stock Company "Farmak" | 48 | 2019-12-13 | 2021-11-18 |
| Progesterone and Resting Energy Expenditure Utrogestan - Menopause, Progesterone | Phase 4 | Terminated | Insel Gruppe AG, University Hospital Bern | 2 | 2019-11-01 | 2022-03-31 |
| Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical Length Micronised vaginal progesterone, Vaginal pessary - Preterm Birth | Phase 3 | Completed | National University of Malaysia | 142 | 2019-10-01 | 2024-01-23 |
| Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. GnRh antagonist, Micronized progesterone - Infertility, IVF | Not applicable | Completed | Fundacion Dexeus | 44 | 2019-09-25 | 2023-05-15 |
| Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route Progesterone 200 mg Soft Capsule (JSC "Farmak", Ukraine), Utrogestan® 200 mg Soft Capsule (Manufacturer: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France) - Pharmacokinetics | Phase 1 | Completed | Joint Stock Company "Farmak" | 66 | 2019-08-28 | 2021-11-18 |
| Endometrial Heparin-binding Epidermal Growth Factor Expression utrogestan - Gene Abnormality | Unknown | National University of Malaysia | 40 | 2019-08-01 | 2019-11-22 | |
| Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients Estradiol Valerate, Micronized progesterone - Miscarriage, Frozen Embryo Transfer | Phase 4 | Terminated | CRG UZ Brussel | 362 | 2019-05-25 | 2025-01-28 |
| Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI Dydrogesterone Oral Tablet, Micronized progesterone, Placebo Dydrogesterone oral tablet - Infertility, Female, Infertility | Phase 4 | Completed | CRG UZ Brussel | 30 | 2019-05-01 | 2020-12-17 |
| Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor micronized progesterone 400 mg (Utrogestan) - Preterm Labor | Phase 4 | Completed | HaEmek Medical Center, Israel | 129 | 2018-12-19 | 2023-02-28 |
Showing 20 of 42. Sign in to see all of them.
Premature Birth (13) · Infertility (8) · Obstetric Labor, Premature (6) · Abortion, Spontaneous (4) · Infertility, Female (2) · Abortion, Threatened (1) · Anxiety Disorders (1) · Depression (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Glioblastoma (1) · Gliosarcoma (1) · Hot Flashes (1) · Long Qt Syndrome 3 (1) · Neoplasm Metastasis (1)
Universitair Ziekenhuis Brussel (4) · HaEmek Medical Center, Israel (3) · CRG UZ Brussel (2) · Joint Stock Company "Farmak" (2) · National University of Malaysia (2) · Shaare Zedek Medical Center (2) · Assaf-Harofeh Medical Center (1) · Besins Healthcare (1) · Chiang Mai University (1) · Chiu Yee Liona Poon (1) · Chulalongkorn University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Dunamenti REK Istenhegyi IVF Center (1) · Emory University (1) · Ewha Womans University Mokdong Hospital (1)
Belgium (6) · Israel (5) · Brazil (3) · Malaysia (3) · Thailand (3) · Canada (2) · Greece (2) · Jordan (2) · Switzerland (2) · Argentina (1) · Austria (1) · Chile (1) · Denmark (1) · Hong Kong (1) · Hungary (1)
Vlad Udovytskyi (2) · Anh D Nguyen, Prof, MD,PhD (1) · Ann Tabor, professor (1) · Begona Martinez de Tejada, MD, PhD (1) · Christophe Blockeel, PhD (1) · Fabio Facchinetti, M.D. (1) · Herman Tournaye, PhD, MD (1) · Hui-Kuo G Shu, MD, PhD, FASTRO (1) · Igor Manuhin, PhD (1) · Jerilynn C Prior, MD, FRCPC (1) · Kypros H Nicolaides, MD, PhD (1) · Line Rode, MD (1) · Liona CY Poon, MD (1) · Maria Brizot, PhD (1)
PMID 25209926, PMID 11804942, PMID 17341565, PMID 17671254, PMID 18275573, PMID 18708050, PMID 19565643, PMID 19733847, PMID 20579989, PMID 20719809, PMID 21481376, PMID 21739497, PMID 21739499, PMID 22086108, PMID 22153789, PMID 22914392, PMID 23157855, PMID 23907942, PMID 24549213, PMID 24945252, PMID 25488942, PMID 26646133, PMID 26649621, PMID 27005893, PMID 27028759, PMID 27149346, PMID 27156350, PMID 28176485, PMID 28594783, PMID 28609128, PMID 30741812, PMID 31087325, PMID 31613412, PMID 32188299, PMID 32478389, PMID 32536019, PMID 32592693, PMID 32653121, PMID 32964939, PMID 33112418, PMID 33307906, PMID 33539543, PMID 33829269, PMID 33946019, PMID 34293771, PMID 34476806, PMID 34730071, PMID 35157571, PMID 35947046, PMID 35972453
2018 (3), 2009 (1), 2014 (1), P30CA138292 (1)